One-Pager

IABP Management

Counterpulsation, triggers, the four timing errors, nursing care and weaning

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources October 2026

Download one-page PDFLetter landscape, ready to print or keep with your notes

How counterpulsation works

A balloon in the descending thoracic aorta fills with helium in diastole and empties just before systole. Light helium moves in and out fast. Support is modest: about 0.5 to 1 L/min of added cardiac output.

PhaseLandmarkEffect
InflateMid T wave; dicrotic notchRaises diastolic pressure and coronary perfusion
DeflateR wave; just before the upstrokeLowers end-diastolic pressure, afterload and O2 demand

Position: tip about 2 cm below the left subclavian (on x-ray, about 2 cm above the carina), lower end above the renal arteries. Check on daily x-ray.

Signs it is working: augmentation above the patient's systole, lower assisted end-diastolic and systolic pressures, rising MAP, cardiac index and urine output, falling PAWP, less chest pain.

Indications and contraindications

Short-term bridge in:

Contraindications:

Triggers and assist ratio

TriggerSensesUse when
ECGR waveFirst choice with a clear R wave
PressureArterial upstrokeNo usable R wave, regular rhythm; CPR
Pacer (V/AV)Ventricular spike100% paced
InternalFixed rate, no triggerOnly with no cardiac ejection (bypass, asystole)

1:1 assists every beat. Check timing at 1:2, where each assisted beat sits beside an unassisted one, then return to 1:1. In atrial fibrillation, consoles deflate on each R wave.

Reading the waveform at 1:2

04080120160mmHg
Correct timing: inflation at the notch makes a sharp V and augmentation peaks above unassisted systole. Assisted end-diastolic pressure and the next systole are both lower: afterload is reduced.
04080120160mmHg
Early inflation: augmentation starts before the notch and cuts into systole. Harm: early aortic valve closure, higher LVEDP and PCWP, more O2 demand.
04080120160mmHg
Late inflation: the notch shows before inflation, with no sharp V; augmentation starts late and lasts a shorter time. Harm: suboptimal coronary perfusion.
04080120160mmHg
Early deflation: a sharp drop soon after the augmented peak leaves a U-shaped dip before systole; assisted systole is not reduced. Harm: little afterload reduction, possible retrograde coronary flow (angina).
04080120160mmHg
Late deflation: assisted end-diastolic pressure equals or exceeds unassisted, and the next systolic upstroke rises slowly. Harm: the LV ejects against a still-inflated balloon, raising afterload and O2 demand.

Nursing care

FindingThinkDo
Cool, pale leg, weak pulsesLimb ischemiaNotify; may need removal
Weak left radial pulseBalloon too high (left subclavian)Check position; notify
Sudden drop in urine outputBalloon too low (renal arteries)Check position; trend creatinine
Blood or dried flecks in gas tubingBalloon perforationStop pumping (see warning)
Site bleeding, falling plateletsAnticoagulation, thrombocytopeniaPressure; labs; notify

Weaning

Practice IABP Management questions free in your browser29 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Counterpulsation physiology in numbers

The balloon displaces its own volume, 25–50 mL, twice every cycle. Inflation at aortic valve closure pushes that volume toward the coronary ostia and arch vessels and down toward the viscera, so peak diastolic pressure rises above the patient's own systolic; deflation just before the valve opens removes it again, so the ventricle ejects into a lower pressure.

Typical numbers with correct timing (Gillespie 2024): assisted end-diastolic pressure 15–20 mm Hg below unassisted (older nursing texts and this app's question bank say 5–15), assisted systolic about 5 mm Hg lower (Parissis 2016 allows up to 10%), cardiac output up 0.5–1 L/min, PAWP and LVEDP down, mean pressure up. Demand falls with afterload and wall stress; supply rises with coronary perfusion pressure (aortic diastolic minus LVEDP). The pump adds no flow of its own, so a ventricle that barely ejects gains little, which is the physiological reading of IABP-SHOCK II; and Kern 1993 found coronary flow beyond a critical stenosis did not rise until the lesion was opened, so the pump buys time for revascularization rather than replacing it.

FactorAugmentationWhy
Heart rate above 110–130FallsDiastole too short to fill and empty
Irregular rhythmErraticPredicted deflation misses; needs R-wave deflation
Vasodilation, hypovolemiaLowLittle volume to displace; pressure does not build
Stiff aged aortaHigherLow compliance: more pressure per mL
Balloon too small, too low or squeezedLowLess displacement reaching the ostia

Catheters, balloons and consoles

Adult catheters are 7–8 Fr: Getinge Linear 7.5 Fr, Sensation 7 Fr and Sensation Plus 7.5–8 Fr (fiber-optic), and Teleflex Arrow UltraFlex 7.5 Fr and FiberOptix 8 Fr. The outer lumen carries helium; the inner takes the guidewire and then transmits aortic pressure. A fiber-optic tip needs no flush; a transduced inner lumen needs a 3 mL/h flush and is never used for blood sampling (Getinge). Membranes run 22–27.5 cm long and 14–18 mm wide; the inflated balloon should fill no more than 90% of the aortic diameter (Gillespie 2024; Teleflex teaches 90–95%).

Cardiosave guide B.17; Teleflex 2025 brochure.
Patient heightGetingeTeleflex Arrow
Under 152 cm (5 ft 0 in)25 cc Linear; 30 cc Mega30 cc from 147 cm
152–162 cm (5 ft 0 to 5 ft 4)34 cc Linear or Sensation; 40 cc Mega or Sensation Plus30 cc (BSA under 1.8 m²)
162–183 cm (5 ft 4 to 6 ft 0)40 cc Linear or Sensation; 50 cc Mega or Sensation Plus40 cc (162–182 cm)
Over 182 cm (6 ft 0 in)50 cc Mega or Sensation Plus50 cc

Getinge Cardiosave (Hybrid in its cart, Rescue for transport) weighs 24 kg in transport trim and runs about 90 minutes per battery with two bays; Teleflex Arrow AC3 Optimus weighs 47 kg and runs 90 minutes on one battery, 180 with a second. Both refill the balloon every 2 hours; each maker supplies an adapter for the other's console.

SettingGetinge CardiosaveTeleflex AC3 Optimus
Operation modesAuto, Semi-AutoAutoPilot, Operator
ECG triggerR wave; pacer spikes rejectedPattern (HR under 130), Peak, AFib
Pressure triggerSystolic upstroke, regular rhythmUpstroke; 3 mm Hg pulse pressure minimum
Internal trigger80 per minute (40–120); no ejection onlyNot on the 2025 specification sheet
Assist ratio1:1, 1:2, 1:31:1, 1:2, 1:4, 1:8
VolumeAugmentation slider, Max to Off0.5–50 cc in 0.5 cc steps
TimingAuto; real-time deflation on the R waveWAVE IntraBeat inflation; R-wave deflation
Augmentation alarm8–10 mm Hg below augmented diastolicAP alarm limit on screen

Who gets one and who should not

The pump helps when the problem is ischemia or afterload and the ventricle still ejects; it cannot oxygenate, unload the right heart or rescue a ventricle with no stroke volume. Among 5,495 MI patients in the Benchmark Registry (Stone 2003), shock and support during PCI each made up 27% of indications and mechanical complications 12%; guidelines have since moved shock without a mechanical lesion off the list.

Contraindications follow the same physiology. Moderate or severe aortic regurgitation: each inflation drives blood back through the valve and raises LVEDP; mild AR is relative. Aortic dissection, aneurysm or a fresh graft: the balloon can extend the tear. Severe aorto-iliac disease or small vessels: limb ischemia, for which the Benchmark Registry (Ferguson 2001) named female sex, peripheral arterial disease, body surface area under 1.65 m² and age 75 or older as predictors. Uncontrolled sepsis, severe coagulopathy and no plan beyond the pump are relative.

Insertion, setup and reading the console

Insertion is Seldinger through the common femoral artery, usually under fluoroscopy. The operator measures from the puncture to the umbilicus and up to the sternal angle to estimate depth, advances the wrapped balloon over the wire and confirms the radiopaque tip 1–2 cm below the left subclavian (Gillespie 2024: 1–2 cm distal to the aortic knob), with a sheathed balloon fully clear of the sheath. In Auto or AutoPilot, START unwraps and fills the balloon, picks lead and trigger, sets timing and calibrates a fiber-optic sensor; the catheter is sutured, the centimeter mark at the skin recorded, and the augmentation alarm set about 3 minutes later.

Balloon pressure is the gas, not the patient: a rounded plateau means the balloon is squeezed (small aorta, sheath, flexed hip), a spike without a plateau means a kink or an unopened membrane.
Console valueExpected at 1:1Deviation means
Augmented diastolicAt or above unassisted systolicLow: rate, SVR, volume, timing, position, gas
Assisted end-diastolic15–20 below unassisted (5–15 older texts)Equal or higher: late deflation
Assisted systolicAbout 5 below unassistedNot lower: early or late deflation
Balloon pressure plateauFlat shelf near augmented diastolicRounded: squeezed; spiked: blocked; low: leak
  1. Set 1:2 and put the reference line on the dicrotic notch of an unassisted beat: inflation should align with it and make a sharp V. A notch visible before the rise is late inflation; a rise cutting into the systolic downslope is early
  2. Is augmentation higher than the patient's systolic? If not, look at rate, volume, filling, SVR and position before touching timing
  3. Does deflation lower assisted systolic and assisted end-diastolic? A U-shaped dip after the peak with no fall in the next systole is early deflation; an assisted end-diastolic at or above unassisted with a slow next upstroke is late
  4. Correct it: in Semi-Auto or Operator mode move the inflation or deflation point a few milliseconds and re-read; in Auto, fix the inputs (lead, gain, trigger, pressure source). Return to 1:1 and chart the six pressures

Troubleshooting alarm by alarm

Technical and high-priority Cardiosave alarms suspend pumping; each opens a help screen of causes and actions. The AC3 Optimus words the same conditions differently (ECG TRIGGER LOSS, ECG LEAD FAULT); the checks do not change.

Prolonged Time in Standby sounds after 10 idle minutes; a balloon still for 30 minutes is a clot risk.
Alarm (Cardiosave)Likely causeCheck firstAction
No TriggerLead off, tiny R wave, artifact, arrestPatient and pulse; leads, lead choice, gainChange lead or source; pacer mode; pressure in CPR
Gas Loss in IAB CircuitLoose connection, slow leak, perforationTubing for blood; every connectionNo blood: tighten, Autofill, START. Blood: stop
Gas Gain in IAB CircuitBlood or fluid entering the gas lumenTubing and extenderTreat as perforation until proven otherwise
IAB Catheter RestrictionKink at the groin, membrane not unfolded, in sheathHip flexion, catheter path, sheath marksStraighten leg; manual inflate to unfold; reposition
Autofill Failure – Blood SuspectedBlood drawn toward the console during a fillTubing, extender, safety chamberStandby, disconnect, clamp, remove; pump out of service
Augmentation Below Limit SetRate up, stroke volume or MAP down; limit too highTiming at 1:2, volume, filling, rhythmTreat the cause; reset the limit if hemodynamics changed
Low Helium, Low BatteryReservoir near empty; off mains, under 30 min leftHelium icon; AC cord, plug icon, second batteryRefill or change cylinder; plug in or swap batteries

If the console stops and no leak is suspected, keep the balloon moving (Getinge): detach the extender, fit a 3-way stopcock and syringe to the male luer, aspirate to confirm no blood returns, inflate with 40 cc of air or helium and aspirate at once, every 5 minutes until a replacement arrives; never inject into the inner lumen. In cardiac arrest the pump stays on: pressure trigger if compressions produce a usable upstroke (Getinge and Gillespie 2024), otherwise internal at 80 per minute, then back to ECG when ejection returns; the console is defibrillator-proof. Restriction, unwrapping and console swaps go to the MCS team; removal is the physician's call.

Complications: prevention, recognition, management

The Benchmark Registry (Ferguson 2001, 16,909 patients) put major complications at 2.6%: major limb ischemia 0.9%, severe bleeding 0.8–0.9%, death caused by the device 0.05%. Parissis 2011 reports thrombocytopenia in up to half of patients and 1.5 times the complication rate once support passes 60 hours.

ComplicationRecognitionPrevention and management
Limb ischemiaCool, pale, pulseless or painful leg; Doppler lossSheathless 7.5 Fr; hourly pulses; remove or move side
Balloon perforationBlood or rust flecks in tubing; gas alarmsStandby, disconnect, clamp, remove within minutes
EntrapmentResistance on withdrawal; clotted balloonNever pull; vascular surgery removes it
Aortic dissectionBack pain, pulse loss, falling Hb, poor augmentationStop pumping; CT or echo; surgery
Thrombocytopenia, HITCount falls; 50% drop, score the 4TsDaily count; stop heparin if HIT likely
Bleeding, retroperitonealSite ooze, hematoma, flank pain, falling HbPressure; review anticoagulation; CT
Embolism, visceral ischemiaNeuro change; abdominal pain, lactate riseKeep the balloon moving; check position

Perforation comes from calcified plaque abrading the membrane. The gas-loss alarm caught only 29% of ruptures in the series Sun 2026 cites, so Getinge asks for a tubing check throughout therapy, and newer Cardiosave software adds a Blood Suspected – Check Catheter and Tubing alarm. Blood in the lumen means helium can embolize through the tear and blood in the balloon clots within minutes: Standby, disconnect the extender so the balloon deflates, clamp the catheter tubing, notify, remove.

Daily care, anticoagulation and transport

Anticoagulation varies more than any other part of IABP care. Many US units run unfractionated heparin to an aPTT of 50–70 seconds (Crimi 2025); others give none, especially after cardiac surgery. Pucher 2012 found one randomized trial (Jiang 2003, 153 patients): limb ischemia 4.2% with heparin vs 2.4% without, no thrombus in either arm, bleeding 14.1% vs 2.4%, and concluded that heparin should follow the patient's other indications, not the pump.

Transport (Gillespie 2024; Cardiosave transport guide): confirm position on film, record pulses, site and the six pressures, secure the catheter and extender, set Auto or AutoPilot with the console's own ECG leads so the trigger does not depend on the transport monitor, and check timing. Carry a full helium reservoir (36 Autofill cycles), two charged batteries or the transport power supply, an adapter for the receiving console and the manual-inflation syringe. Vibration corrupts the ECG, so a pressure trigger from the fiber-optic tip is the fallback. Helium expands as cabin pressure falls, so the Cardiosave purges and refills when ambient pressure drops 25 mm Hg (about every 1,000 ft of climb) or rises 50 mm Hg (every 2,000 ft of descent).

Weaning, removal and aftercare

Weaning starts when the reason for the pump has been treated (revascularization done, surgery over, rhythm controlled) and the patient is stable on little vasoactive support; one proposed set is MAP above 65 mm Hg, heart rate under 100, cardiac index over 2.2 L/min/m², lactate under 2 mmol/L and no new ischemia (Dangl 2023, written for temporary MCS in general). After each step recheck pressure, heart rate, cardiac index or ScvO₂, PAWP, urine output and lactate.

Low ratio and low volume are stations on the way out, not places to stay.
StrategyHowEvidence
Ratio weaning1:1 to 1:2 for hours, then 1:3 briefly, then outMost common (Rogers 2016); outcomes equal
Volume weaningAugmentation reduced stepwise toward minimumOne RCT favored it on hemodynamics (Rogers 2016)

Removal: hold heparin until the aPTT is near normal (many units wait 2–4 hours or until the ACT is below 150–180 seconds), put the console in Standby so the balloon is deflated and aspirated, withdraw the balloon into the sheath if one is in and remove both together, let the artery bleed back for a beat to flush clot, then hold pressure 30–45 minutes. Afterward: head of bed 30° or less with the leg straight for 4–6 hours, pulses and site every 15 minutes for an hour, then hourly; watch for retroperitoneal bleeding (flank pain, falling hemoglobin, tachycardia) and pseudoaneurysm (pulsatile mass, bruit).

Evidence and controversies

TrialPatients and designMain resultEffect on practice
IABP-SHOCK II (2012)600 MI shock, early revascularization30-day death 39.7% vs 41.3%, P=0.69Routine IABP in MI shock downgraded
CRISP AMI (2011)337 anterior STEMI, no shock, IABP before PCIInfarct 42.1% vs 37.5% of LV mass, NSNo prophylactic IABP in STEMI
BCIS-1 (2010)301 high-risk PCI, LVEF 30% or lessMACCE 15.2% vs 16.0%; HR 0.66 at 51 monthsSelective, not routine, in high-risk PCI
DanGer Shock (2024)355 STEMI shock, microaxial pump vs standard180-day death 45.8% vs 58.5%, HR 0.74Microaxial pump 2a in selected STEMI shock
ALTSHOCK-2 (2025)101 heart-failure shock, early IABPSurvival or bridge at 60 days 81% vs 75%Stopped for futility; no routine IABP in HF shock

IABP-SHOCK II (Thiele 2012; 600 patients, nearly all revascularized early): mortality 39.7% vs 41.3% at 30 days (relative risk 0.96), 52% vs 51% at 12 months (Thiele 2013) and 66.3% vs 67.0% at 6 years (Thiele 2019), with the same complications (major bleeding 3.3% vs 4.4%, peripheral ischemia 4.3% vs 3.4%). BCIS-1 is the one trial with a late signal: mortality at 51 months 27.8% vs 38.7% (Perera 2013).

Guidelines followed. The 2004 ACC/AHA STEMI guideline had IABP in shock at Class I; ACC/AHA dropped it to IIa in 2013, ESC moved routine use to Class III while keeping IIa for mechanical complications (a split the 2023 ESC ACS guideline retains), and the 2025 ACC/AHA ACS guideline lists routine IABP, and routine VA-ECMO, as Class 3 No Benefit while giving a microaxial flow pump a 2a for selected STEMI shock on DanGer Shock (Møller 2024), whose survival gain came with severe bleeding, limb ischemia, hemolysis or device failure in 24.0% vs 6.2%.

Unsettled: whether any shock subgroup benefits (insertion before PCI, SCAI stage B–C, patients too frail for a larger device), whether heparin helps or only bleeds, which weaning method is better, and whether axillary IABP as an ambulatory bridge to transplant changes outcomes.

Exam pearls

Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Related one-pagers

Calculators for this topic

Sources

  1. Getinge. Cardiosave IABP Operation – Transport Quick Reference Guide, software B.17 (MCA00001036 Rev B, 09/2023). Link
  2. Getinge. Addendum to Cardiosave IABP Operating Instructions – Clinical Considerations: IAB IFU Balloon Membrane Perforation (MCA000000556 Rev C, 10/2023). Link
  3. Gillespie LE, Lane BH, Shaw CR, et al. The Intra-aortic Balloon Pump: A Focused Review of Physiology, Transport Logistics, Mechanics, and Complications. J Soc Cardiovasc Angiogr Interv. 2024;3(5):101337. Link
  4. Fortuni F, et al. Management of temporary mechanical circulatory support devices in cath-lab and cardiac intensive care unit. Eur Heart J Imaging Methods Pract. 2023;1(1):qyad011. Link
  5. Parissis H, et al. IABP: history-evolution-pathophysiology-indications: what we need to know. J Cardiothorac Surg. 2016;11:122. Link
  6. Dangl M, Albosta M, Butros H, Loebe M. Temporary Mechanical Circulatory Support: Left, Right, and Biventricular Devices. Curr Cardiol Rev. 2023;19(5):e140323214613. Link
  7. Rogers L, Cochrane E, Blundell D, Zakkar M. What is the optimum method of weaning intra-aortic balloon pumps? Interact Cardiovasc Thorac Surg. 2016;23(2):310-313. doi:10.1093/icvts/ivw122. Link
  8. Crimi E, Rajkumar K, Coleman S, et al. Cardiovascular Physiology During Mechanical Circulatory Support: Implications for Management and Monitoring. J Clin Med. 2025. Link
  9. Pucher PH, et al. Is heparin needed for patients with an intra-aortic balloon pump? Interact Cardiovasc Thorac Surg. 2012;15(1):136-139. Link
  10. Wong ASK, Sin SWC. Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, ECMO, TandemHeart): a review. Ann Transl Med. 2020;8(13):829. Link
  11. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock (IABP-SHOCK II). N Engl J Med. 2012;367(14):1287-1296. doi:10.1056/NEJMoa1208410. Link
  12. You L, et al. Intra-aortic balloon pump use and in-hospital mortality in acute myocardial infarction with Killip class III or IV: a nationwide cohort study. Biomark Res. 2026;14:97. Link
  13. Bhardwaj A, Hillerson D, Narang N, Pelter MN, et al. Evolving Evidence-Driven Strategies in Cardiogenic Shock Management. JACC Adv. 2026;5(10):103225. Link
  14. Giamundo DM, Andò G, Mamas MA, et al. Contemporary Management of Acute Coronary Syndromes in the Cardiac Intensive Care Unit. J Cardiovasc Dev Dis. 2026;13:393. Link
  15. Sun G, Wang S, Xiong C, Wei Y, et al. Management of intra-aortic balloon pump rupture and entrapment: a case report and review of the literature. Int J Surg Case Rep. 2026;138(5):1741-1748. Link
  16. AACN Certification Corporation. CCRN Exam Handbook – Direct Care (Adult), July 2026. Link